Dr. Michael Bishop's research focuses on using stem cell transplantation for a
variety of malignant disorders—including leukemias, lymphomas, multiple myeloma,
and metastatic breast cancer
Born in Eldorado, Illinois, Dr. Bishop earned his medical degree from the College of
Medicine at University of Illinois in Chicago. Concentrating on the dual disciplines
of hematology and oncology, he completed both his internship and his residency in medicine
at Northwestern Memorial Hospital in Chicago and a fellowship in hematology/oncology at
Loyola University Medical Center, Maywood, Illinois.
Prior to coming to NIH, Dr. Bishop held the position of Associate Professor of Medicine
in oncology/hematology at University of Nebraska Medical Center. While there he also
served as director of the Leukemia and Allogeneic Stem Cell Transplantation Programs.
In 1999, Dr. Bishop joined the National Cancer Institute as a clinical investigator and
leader of the stem cell transplantation program. He continues to lead that program today
as Clinical Head in NCI's Experimental Transplantation and Immunology Branch.
Dr. Bishop has received many honors and awards, including being named Top Teacher in
Internal Medicine at the University of Nebraska Medical Center for three years in a row—in 1996, 1997,
and 1998. He also was listed in the national edition of The Best Doctors in America for 2001 and 2002.
Among Dr. Bishop's professional service activities, he currently sits on the editorial board of
NCI's Cancer Trials and has served as a reviewer for 17 journals—including American Journal of Medicine,
Leukemia & Lymphoma, and the Journal of Clinical Oncology. The American Board of Internal Medicine,
American Society of Clinical Oncology and American Society of Hematology are among his professional memberships.
He has authored and co-authored 92 articles, 130 abstracts, and 19 book chapters.
Medicine
for the Public home
|
